153 related articles for article (PubMed ID: 25846732)
1. The M30 assay does not detect apoptosis in epithelial-derived cancer cells expressing low levels of cytokeratin 18.
Cevatemre B; Ulukaya E; Sarimahmut M; Oral AY; Frame FM
Tumour Biol; 2015 Sep; 36(9):6857-65. PubMed ID: 25846732
[TBL] [Abstract][Full Text] [Related]
2. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
Olofsson MH; Cummings J; Fayad W; Brnjic S; Herrmann R; Berndtsson M; Hodgkinson C; Dean E; Odedra R; Wilkinson RW; Mundt KE; Busk M; Dive C; Linder S
Cancer Biomark; 2009; 5(3):117-25. PubMed ID: 19407366
[TBL] [Abstract][Full Text] [Related]
3. M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.
Chu T; Jiang L; Ying W; Han B
Clin Transl Oncol; 2017 Mar; 19(3):326-331. PubMed ID: 27468866
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
[TBL] [Abstract][Full Text] [Related]
5. High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients.
Koch A; Yagmur E; Linka J; Schumacher F; Bruensing J; Buendgens L; Herbers U; Koek GH; Weiskirchen R; Trautwein C; Tacke F
Dis Markers; 2018; 2018():8583121. PubMed ID: 30069276
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of apoptosis and M30 expression in colonic cancer progression.
Kykalos S; Dimitroulis D; Ntikoudi E; Karayiannakis A
J Recept Signal Transduct Res; 2013 Aug; 33(4):255-9. PubMed ID: 23767766
[TBL] [Abstract][Full Text] [Related]
7. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.
Linder S; Olofsson MH; Herrmann R; Ulukaya E
Expert Rev Mol Diagn; 2010 Apr; 10(3):353-9. PubMed ID: 20370591
[TBL] [Abstract][Full Text] [Related]
8. Optimisation of circulating biomarkers of cell death for routine clinical use.
Greystoke A; Cummings J; Ward T; Simpson K; Renehan A; Butt F; Moore D; Gietema J; Blackhall F; Ranson M; Hughes A; Dive C
Ann Oncol; 2008 May; 19(5):990-5. PubMed ID: 18304966
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study.
Adebayo D; Morabito V; Andreola F; Pieri G; Luong TV; Dhillon A; Mookerjee R; Jalan R
Liver Int; 2015 Dec; 35(12):2564-74. PubMed ID: 25879577
[TBL] [Abstract][Full Text] [Related]
10. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
[TBL] [Abstract][Full Text] [Related]
11. Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.
Fisher MB; Zhang XQ; McConkey DJ; Benedict WF
Cancer Gene Ther; 2009 Jul; 16(7):567-72. PubMed ID: 19197325
[TBL] [Abstract][Full Text] [Related]
12. The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival.
Ulukaya E; Yilmaztepe A; Akgoz S; Linder S; Karadag M
Lung Cancer; 2007 Jun; 56(3):399-404. PubMed ID: 17316892
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the biological effects of 125I seeds continuous low-dose-rate radiation and 60Co high-dose-rate gamma radiation on non-small cell lung cancer cells.
Wang Z; Zhao Z; Lu J; Chen Z; Mao A; Teng G; Liu F
PLoS One; 2015; 10(8):e0133728. PubMed ID: 26266801
[TBL] [Abstract][Full Text] [Related]
14. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.
Ausch C; Buxhofer-Ausch V; Olszewski U; Hinterberger W; Ogris E; Schiessel R; Hamilton G
Eur J Surg Oncol; 2009 Nov; 35(11):1164-8. PubMed ID: 19254831
[TBL] [Abstract][Full Text] [Related]
15. Utility of M30, an apoptotic serum marker, in liver diseases.
Altinbaş A; Çoban Ş; Başar Ö; Yüksel O
Turk J Med Sci; 2015; 45(1):6-10. PubMed ID: 25790523
[TBL] [Abstract][Full Text] [Related]
16. Circulating biomarkers of cell death after treatment with the BH-3 mimetic ABT-737 in a preclinical model of small-cell lung cancer.
Micha D; Cummings J; Shoemaker A; Elmore S; Foster K; Greaves M; Ward T; Rosenberg S; Dive C; Simpson K
Clin Cancer Res; 2008 Nov; 14(22):7304-10. PubMed ID: 19010845
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.
Cummings J; Hodgkinson C; Odedra R; Sini P; Heaton SP; Mundt KE; Ward TH; Wilkinson RW; Growcott J; Hughes A; Dive C
Mol Cancer Ther; 2008 Mar; 7(3):455-63. PubMed ID: 18347133
[TBL] [Abstract][Full Text] [Related]
18. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
19. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin markers come of age.
Linder S
Tumour Biol; 2007; 28(4):189-95. PubMed ID: 17717426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
